STADA Arzneimittel AG

Report Publication Announcement • Aug 17, 2022

News Details

Advance Financial Reports | 17 August 2022 09:49

STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

STADA Arzneimittel AG / Preliminary announcement on the disclosure of financial statements

STADA Arzneimittel AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

17.08.2022 / 09:49 CET/CEST

Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

STADA Arzneimittel AG hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German

Date of disclosure: August 25, 2022

Address: https://www.stada.com/de/finanzberichte/h1-2022.pdf

Language: English

Date of disclosure: August 25, 2022

Address: https://www.stada.com/financial-publications/h1-2022.pdf

---

17.08.2022 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	STADA Arzneimittel AG
	Stadastraße 2-18
	61118 Bad Vilbel
	Germany
Internet:	www.stada.de

End of News	DGAP News Service